Auto Immune Diseases Market Pipeline Assessment of Medical Devices in New Research Report

Feb 08, 2016, 21:00 ET from ReportsnReports

PUNE, India, February 9, 2016 /PRNewswire/ -- adds Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015 market research report that provides an overview of autoimmune diseases currently in pipeline stage to the medical devices collection of its online library.

Complete report on auto immune diseases market medical devices pipeline spread across 295 pages mentioning 96 companies and organizations as well as supported with 127 tables and 4 figures is now available at .

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Auto-Immune Diseases pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Companies, organizations and their pipelines mentioned in this autoimmune diseases market medical devices assessment report include Adaptive Biotechnologies Corporation, Agena Bioscience, Inc, Albert-Ludwigs-Universitat Freiburg, Alere Inc., Amarantus Bioscience Holdings, Inc., Amdix B.V., Analyticon Biotechnologies AG, apDia n.v., Autoimmune Technologies, LLC, Beckman Coulter, Inc., BG Medicine, Inc., Biocortech, Biogen, Inc., Biomedal S.L., Biomerica, Inc., Bionure Farma, S.L., Bio-Rad Laboratories, Inc., BioRap Technologies Ltd., Boston University, CareDx, Inc., CD Diagnostics, Inc., Chronix Biomedical, Inc., Co-Diagnostics HBDC, Inc., Crescendo Bioscience, Inc., Digna Biotech, S.L., Durin Technologies, Inc., Enterome Bioscience SA, Ezose Sciences Inc., Flamentera AG, Genalyte, Inc., Genentech, Inc., GeNeuro SA, Glycominds Ltd., Grifols, S.A., Hannover Medical School, Helmholtz Centre for Infection Research, HOB Biotech Group Co., Ltd. , Hospital for Special Surgery, Hycor Biomedical Inc., Ignyta, Inc., ImmusanT, Inc., Innobiochips, INOVA Diagnostics, Inc., Institut National de la Sante et de la Recherche Medicale, Is Diagnostics, LineaGen, Inc., Lophius Biosciences GmbH, Louisville Bioscience, Inc., Max-Delbruck-Centrum fur Molekulare Medizin (MDC), Medica Corporation, Metabolomic Technologies Inc., Metanomics Health GmbH, MSDx, Inc., Myriad Genetics, Inc., Nanosphere, Inc., Neuro Vigor, LLC, Northwestern University, NoToPharm s.r.l., NOWDiagnostics , OmniBiome Therapeutics Inc., One Way Liver Genomics, S.L., OPKO Health, Inc., Oxford Gene Technology Limited, Oxford Immunotec Limited, Pediatric Bioscience, LLC, Progentec Diagnostics, Inc., Protagen AG, ProteinLogic Ltd, Quanterix Corporation, Regulus Therapeutics Inc., Rice University, Roche Diagnostics International Ltd., Shuwen Biotech Co. Ltd., Singulex, Inc., SomaLogic, Inc., Southern Illinois University Carbondale, SQI Diagnostics Inc., The Johns Hopkins University, The Walter and Eliza Hall Institute of Medical Research, TheraDiag SA, Thermo Fisher Scientific Inc., Toscana Biomarkers Srl, Univalue Valorizacion, S.L., University of California, San Francisco, University of Chicago, University of Colorado, University of Florida, University of Manchester, University of Oxford, University of Pecs, University Rovira i Virgili, US Biomarkers, Inc., Washington University in St. Louis, XAir Diagnostics B.V., XEPTAGEN SpA and Yale University. Order a copy of Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015 market research report at .

On a related note, a bit dated but relevant research titled Autoimmune Disease Partnering Terms and Agreements provides comprehensive understanding and unprecedented access to the autoimmune disease partnering deals and agreements entered into by the worlds leading healthcare companies. This report contains a comprehensive listing of all autoimmune disease partnering deals announced since 2010 including financial terms where available, including over 700 links to online deal records of actual autoimmune partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. In addition, a comprehensive appendix is provided with each report of all autoimmune disease partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The report also includes numerous tables and figures that illustrate the trends and activities in autoimmune partnering and dealmaking since 2010. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of autoimmune disease technologies and products. Read more at .

Explore more reports on medical devices market at .

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441

Connect With Us on:  




G+ / Google Plus:


SOURCE ReportsnReports